In June, there was over $15 billion raised by companies in the biotech and biopharma space. Within this blog, we delve into our key findings, and the companies raising these funds. You can subscribe to monthly biotech funding updates over on my LinkedIn to keep up to date with the ever-growing biotech market.

 


 

The largest amount of money raised was by Novartis who raised $2.49 billion in Post-IPO Debt.

The largest amount raised by a private company was by Curie.Bio who raised $380 million in their series A funding round.

$2.94 billion was raised between Pre-Seed and Series E funding rounds. The table below shows the full breakdown.

 

funding round table

pre-seed funding

 

149,770 Hummsa Biotech (India) At Hummsa Biotech, we are pioneering a transformative theragnostic approach by harnessing the power of synthetic biology.

500,000 Cypris Therapeutics (NY, USA) is leveraging their proprietary synthetic chemistry and drug development expertise to create next generation therapies for unmet clinical needs.

3,935,409 NXI Therapeutics (Switzerland) develops next-gen immunosuppressive drugs for autoimmune diseases and organ transplantation.

 

seed funding

 

Unknown BioGeometry (China) is an Innovative digital biology startup that specializes in using generative AI in protein creation.

Unknown Weikang Pingsheng (China) is developing pharmaceutical delivery technology, based on lipid droplet biology.

Unknown Hangzhou Weiyuan Biotechnology (China) is a synthetic biology research and development company that specializes in enzyme advancement.

Unknown Recorna Bio (China) is a biotechnology company that provides research and development for RNA editing and genome modifications.

Unknown Meiyou Technology (China) is a DNA synthesizer developer focusing on enzymatic long-fragment DNA synthesis and splicing technology.

Unknown Zhongshenghong Biotech (China) is a biopharmaceutical developer that focuses on medical research and experimental development.

Unknown Microevolution Medical (China) is a cross-species tumor gene therapy service provider.

Unknown Suzhou Pelotin Biotechnology (China) is a research firm specializing in peptides, recombinant proteins, GE antibodies, and protein expression.

Unknown Huili Biotech (China) is a developer of electrochemical biosensors. It specializes in medical gadgets such as in vitro diagnostic test kits and microbial detection and analysis instruments.

Unknown Supercede Therapeutics (CA, USA) is researching small molecule therapies.

413,490 Renda Kangjian (China) is an anti-Alzheimer’s medicine developer company.

500,000 Citizen Labs (United Kingdom) is a leader of handcrafted, small-batch, superior quality cannabis products in the medical segment.

825,363 ŌGI Bio (United Kingdom) is a newly formed start-up company from The University of Edinburgh with the mission to revolutionize the way that microbes are grown and managed.

1,099,998 Intolerant Antibodies (CA, USA) is a stealth mode biopharmaceuticals and healthcare company.

1,378,302 Cancer Cell (China) is an animal tissue pathology testing service provider company.

3,000,000 Saguaro (Canada) offers new drug discovery technologies that help fight human disease.

4,130,638 Yinwa Biotech (China) is a digital human development company that specializes in the fusion of digital and biotechnology.

6,000,000 Ability Biologics (Canada) dedicated to developing the most potent and selective antibody therapeutics for areas of great unmet need.

6,500,000 TwoStep Therapeutics (CA, USA) is developing novel tumor-targeting therapeutics for solid tumors.

7,000,000 Leman Biotech (Switzerland) is a biotech company that is engaged in development of cancer immunotherapies.

7,055,232 BIOPHTA (France) has pioneered a novel approach to eye care by creating a cutting-edge pharmaceutical platform that enables continuous drug delivery.

7,538,635 Tacalyx (Germany) is a biotech company focused on the discovery and development of novel anti-TACA.

8,000,000 Psylo (Australia) is a drug development company that focuses on next-generation psychedelics.

10,000,000 EpilepsyGTx (United Kingdom) is a late-stage biotech company exploring cutting-edge gene therapies to improve the management of focal refractory epilepsy.

10,000,000 Deepin Technology (China) focuses on chemistry research using artificial intelligence.

13,758,564 Phrontline Biopharma (China) specializes in the development of ADC to address unmet medical needs in the field of oncology.

14,500,000 Waypoint Bio (NY, USA) is optimizing cell therapy with spatial biology.

32,308,437 Adcytherix (France) is a biopharmaceutical firm that specializes in the development of new antibody drug conjugates (ADC).

142,000,000 EvolutionaryScale (NY, USA) is a developer of biological artificial intelligence models for therapeutic design.

 

series-a funding

 

Unknown Hooke Instruments (China) is a manufacturer of high-end optical life science instruments.

Unknown USK Biotech (China) is a company that develops molecular diagnostic technologies and products. USK Biotech primarily focuses on in vitro molecular diagnostics, integrating product research and development, manufacturing, marketing, and services, and has established a complete molecular diagnostic industrial chain.

6,222,736 Dioseve (Japan) has revolutionary technology, DIO (Directly Induced Oocyte), which is capable of producing a large yield of fertilizable egg cells at a minimal cost in a fraction of the time.

7,500,000 Alida Biosciences (CA, USA) is a biotech company creating RNA analysis tools to improve human health.

13,801,860 Genewise Bio (China) is a biotechnology company that specializes in the technological iteration of POCT in molecular diagnostics.

13,802,050 Thorough Future (China) helps in integrating cutting-edge technology into medical care, delivering more accurate and efficient diagnostic services.

16,000,000 Holoclara (CA, USA) is a immunotherapy company that offers autoimmune disorders with nematode derived molecules.

18,206,937 Augustine Therapeutics (Belgium) is discovering and developing innovative medicines for the treatment of neuromuscular and neurodegenerative diseases.

21,000,000 Vilya (WA, USA) is a biotechnology company developing a novel class of drugs that precisely target the biology of disease.

26,000,000 Moleculent (Sweden) is adding a functional layer of biology to pave the way for unparalleled advancements in life science.

27,420,813 Turbine (Hungary) has a platform that understands the inner mechanisms of cancer enabling the discovery of novel targets & precision medicinal therapies.

28,000,000 Rapafusyn Pharmaceuticals (MD, USA) licenses technology related to a novel class of natural product-like macrocycle.

32,000,000 Advanced Medicine Partners (IL, USA) is a biotechnology company that specializes in viral vector manufacturing for genes and cells.

40,000,000 Äshibio (CA, USA) is a privately held biotechnology business exploring innovative therapies to treat bone and connective tissue ailments.

48,000,000 Cradle (CA, USA) is a cryonics company that develops and proves the feasibility of human organs and whole-body reversible cryopreservation. That aims to focus on pausing and restarting biological functions through freezing to prevent tissue damage in dead bodies.

82,000,000 Exsilio (MA, USA) develops genomic therapeutics that introduce therapeutic genes into safe shelters within the DNA.

85,000,000 InduPro (WA, USA) is a biotechnology company that specializes in protein therapeutics and cell-surface platform technologies.

101,703,017 Amber Therapeutics (United Kingdom) develops the next-generation of bioelectrical therapies.

380,000,000 Curie.Bio (MA, USA) is a founder-focused seed-stage venture firm combined with an industry-grade therapeutics accelerator focused on one thing: helping entrepreneurial founders launch viable therapeutics companies.

 

series b funding

 

Unknown Chengdu Pukang Biotechnology Co., Ltd (China) develops and supplies PEG derivatives, polypeptide drug side chains, and intermediates.

Unknown Innostellar Biotherapeutics (China) is a biopharmaceutical startup that focuses on gene therapy for novel medication research and manufacturing.

Unknown Dingzhi Biotech (China) is a manufacturing company that develops biopharmaceutical products including animal vaccines.

11,984,412 GPN Vaccines (Australia) is a vaccine that is used to prevent the spread of streptococcus pneumoniae.

25,000,000 Envisagenics (NY, USA) reduce the complexity of biomedical data to accelerate the development of innovative therapeutic solutions.

51,432,536 Interius BioTherapeutics (PA, USA) is a biopharmaceutical company that develops in vivo cell-specific gene medicines to treat B cell lymphomas.

55,000,000 Enveda Biosciences (CO, USA) is a biotechnology company engineering new drugs from plants.

55,000,000 Prolific Machines (CA, USA) is ushering in a new era of biotechnology using light. Their photo molecular biology platform leverages safe and effective tools — light, bioengineering, hardware, and AI — for dynamic control over virtually any cell function in any cell type.

81,000,000 Elion Therapeutics (MA, USA) is a cutting-edge biotechnology business focused on treating life-threatening IFIs.

85,650,537 iOnctura (Switzerland) is a clinical-stage biotechnology company that specializes in developing treatments for cancer.

125,000,000 Santa Ana Bio (CA, USA) is a biotechnology company focusing on precision immunology for autoimmune and inflammatory diseases.

170,000,000 Beacon Therapeutics (United Kingdom) is an ophthalmic gene therapy company to treat blinding retinal illnesses and restore and enhance eyesight.

190,000,000 Marea (CA, USA) is a biotechnology firm that uses the advancements in human genetics next-generation medications for cardiometabolic illnesses.

 

series-c funding

 

Unknown MAXVAX (China) aims to provide novel vaccine development and commercialization.

20,000,000 Frontier Medicines (CA, USA) is a biopharmaceutical company that develops a chemo proteomics platform to accelerate the development of medicines.

90,000,000 Bright Peak (Switzerland) is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases.

100,000,000 METiS Pharmaceuticals (China) is the world’s first AI-driven drug formulation company.

 

series-d funding

 

Unknown Gensciences (China) offers new drug research and development, production, and sales. They offer innovative drugs, strive for high safety, high effectiveness, and a high success rate simultaneously, become a continuous innovator in the global biopharmaceutical field, and benefit patient groups.

50,000,000 Osteal Therapeutics (TX, USA) is a clinical-stage specialty pharmaceutical company developing novel treatments for orthopaedic infections.

130,000,000 BillionToOne (CA, USA) is a precision diagnostics company that focuses on genetic testing for disease detection.

372,000,000 Formation Bio (NY, USA) is a drug development company that strives to provide treatments to patients faster by reimagining clinical trials.

 

series-e funding

 

100,000,000 Alzheon (MA, USA) is a clinical-stage biotechnology company that develops treatment for neurodegenerative disorders.

 

grant funding

 

Unknown Siren Biotechnology (CA, USA) blends two revolutionary therapeutic technologies into one for a novel approach to treating cancer.

Unknown ReproCELL Incorporated (Japan) is primarily engaged in the development of stem cell technologies.

Unknown PartitionBio (United Kingdom) engages in technology platform that develops biomolecular tools for therapeutic and synthetic biology applications.

Unknown ReviR Therapeutics (CA, USA) is a genomics-based platform that develops novel medicines targeting human RNAs.

Unknown Metabolon (NC, USA) offers metabolomics solutions that enhance life sciences research, diagnostics, and precision medicine.

Unknown SNIPR Biome (Denmark) is a operator of a discovery stage biotech company intended to revolutionize the treatment of microbial diseases.

26,802 GynTools (Israel) develops the first of its kind point-of-care diagnostics solution for gynaecologists.

53,401 Invitrolize (Luxembourg) provides innovative 3D alveolar in vitro models that allow to prediction of the hazard of respiratory sensitization and irritation.

75,000 Intuitive Biosciences (WI, USA) provides tuberculosis and specific pathogen-free tests for non-human primate (NHP) research operations.

167,839 Calico Biosystems (Switzerland) is a cancer testing platform.

400,000 Seraxis (MD, USA) is a privately owned biotechnology company developing a practical and potent cell replacement therapy for insulin-dependent diabetes.

535,498 CTIBiotech (France) is a biotechnology company that specializes in cancer research, stem cells, government advisor, and medical journal reviewers.

595,000 Alchemab Therapeutics (United Kingdom) is developing protective antibodies designed to keep people free of hard-to-treat diseases.

825,000 Delix Therapeutics (MA, USA) focuses on harnessing the power of psychoplastogens novel neuroplasticity-promoting therapeutic.

998,064 Canomiks’ (MN, USA) genomics, bioinformatics, and AI-based Product Superiority Platform helps companies create safe and efficacious products.

1,000,000 Fuse Diagnostics (United Kingdom) vision is to give lab quality diagnostic information wherever it is required through innovative, quick, low-cost testing.

1,000,000 Prompt Diagnostics (MD, USA) is a biotechnology firm that diagnosis with sensitivity and specificity for detection of disease at the point-of-care.

1,000,000 ProJenX (NY, USA) is a biopharmaceutical company that develops novel small molecule therapeutics that target motor neuron degenerative pathways.

1,095,313 Virica Biotech (Canada) is a biotechnology company that addresses the unmet needs in production and development to positively change human health.

1,300,000 Charles River Laboratories (MA, USA) is a pharmaceutical company that offers laboratory products and services for drug discovery.

1,457,718 Nuclera (United Kingdom) offers a protein prototyping system to accelerate drug discovery by making proteins readily available to researchers.

1,493,409 Kannalife (PA, USA) is a biopharmaceutical company that focuses on innovation in research and development of novel cannabinoid therapeutic agents.

1,700,000 Opus Genetics (NC, USA) is a gene therapy company for ultra-rare blinding conditions.

1,900,000 Rumi Scientific (NY, USA) offers a flexible suite of services to complement its neuro-based research and drug discovery program.

1,990,000 KeViRx (VA, USA) is a biotechnology company that develops therapeutics for cancer and respiratory disorders.

2,050,000 Constantiam Biosciences (TX, USA) specializes in integrated computational modelling and high-throughput experimentation via MAVEvidence, a functional evidence resource for the clinical genetics community.

3,400,000 Tiziana Life Sciences (United Kingdom) ‘s mission is to bring breakthrough therapies to patients to treat Non-Active Secondary Progressive Multiple Sclerosis, Alzheimer’s, ALS and other neuroinflammatory and neurodegenerative indications to optimize health outcomes.

15,000,000 Ensysce Biosciences (CA, USA) develops an abuse-deterrent and overdose technology that can be applied to 75% of all marketed drugs.

100,000,000 St. Jude Children’s Research Hospital® (TN, USA) is a paediatric treatment and research institution focused on childhood cancer and other diseases.

 

corporate round

 

6,512,522 NLC (The Netherlands) is the European HealthTech venture builder, bringing science-based HealthTech inventions to life.

 

convertible note

 

12,345,016 Sanity Group (Germany) is a cannabis company that provides cannabinoid-based pharmaceuticals and well-being products.

 

private equity

 

Unknown K2 Medical Research (FL, USA) is a clinical research centre that specializes in conducting clinical trials.

Unknown Analytical Biological Services (DE, USA) provides bespoke biological products and services including Cell Culture Services, Cell-Line Engineering, Human Biospecimens, Cell and Tissue Preparations and Analyses, and Sample Storage and Logistics.

35,000,000 Boston Oncology (MA, USA) is a healthcare of citizens in emerging markets around the world through regional development and production of licensed.

50,000,000 Spur Therapeutics (United Kingdom) is a clinical-stage biotechnology business dedicated to creating life-changing medicines for crippling chronic illnesses.

204,559,055 Isotopen Technologien Münchenis (Germany) a biotechnology and radiopharmaceutical group of companies dedicated to the development, production and global supply of targeted diagnostic and therapeutic radiopharmaceuticals and radioisotopes for use in cancer treatment.

post-ipo

 

163,612 Ikonisys (CT, USA) is a leading cell-based diagnostics company that markets the proprietary Ikoniscope® Digital Microscope, engineered to provide highly accurate and reliable detection of rare cells.

270,000 BioNxt Solutions (Canada) mission is to develop and commercialize next-generation pharmaceuticals.

786,660 NLS Pharma (Switzerland) is a clinical-stage drug development company focusing on neurobehavioral and neurocognitive disorders and their pharmacognosia.

995,565 Dancann Pharma (Denmark) manufactures medical cannabis and develops novel cannabinoid therapeutics for a broad range of diseases.

1,100,000 Oragenics (FL, USA) is a development-stage company that primarily engages in fighting infectious diseases.

1,370,000 CNS Pharmaceutical (TX, USA) is a pre-clinical stage biotechnology company specializing in the development of novel treatments for brain tumors.

1,860,000 Cingulate Therapeutics (NJ, USA) uses a unique combination of delivery technology and proven medications that creates an unmatched release profile.

2,080,000 Tharimmune (United Kingdom) (previously Hillstream BioPharma) is a development-stage company advancing improved therapies for patients with cancer.

2,500,000 Mustang Bio (NY, USA) is a clinical-stage bio-pharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors and rare genetic diseases.

2,522,371 TME Pharma (Germany) develops biostable aptamers and substances based on mirror image nucleic acids.

2,750,000 Aptevo Therapeutics (WA, USA) is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market.

3,000,000 Willow Biosciences (Canada) is a multidisciplinary team of discovery biologists, biochemists and geneticists.

3,330,587 Incanthera Ltd. (United Kingdom) develops cancer treatment drugs. Its ICT-2588 is a lead compound that is activated within solid tumours.

3,500,000 Aytu BioScience (CO, USA) is a specialty healthcare company focused on developing treatments for urological and related conditions.

3,969,205 PEPTONIC medical AB (Sweden) is a pharmaceutical company, develops oxytocin based products for the treatment of menopausal symptoms.

4,000,000 Bio-Path Holdings (TX, USA) is a biotechnology company developing therapeutic products for the liposomal delivery of nucleic acids in cancer patients.10,500,000 BCAL Diagnostics (Australia) is a biotechnology company that focuses on the detection of women’s health issues.

4,000,000 Tonix Pharmaceuticals (NY, USA) develops pharmaceutical products for central nervous system disorders.

4,000,000 Brainstorm (MA, USA) is a developing innovative, autologous stem cell therapies for highly debilitating neurodegenerative disorders.

4,000,000 GRI Bio (CA, USA) is a biotech company that develops therapies to treat inflammatory diseases.

4,300,000 Coeptis Therapeutics (PA, USA) focuses on the development and acquisition of pharmaceutical products.

4,400,000 Longeveron (FL, USA) is a biotechnology company that focuses on developing cellular therapies for chronic aging-related and life-threatening diseases.

4,995,374 RadioPharm Theranostics (Australia) is a platform of radiopharmaceutical and nuclear medicine products for diagnostic and therapeutic uses.

5,000,000 Eyenovia (NY, USA) is a biopharmaceutical company that provides a portfolio of next generation topical eye treatments.

8,433,936 Phaxiam (France) develops bacteriophage-based therapies to combat antimicrobial resistance in bacterial infections.

11,500,000 Elicio Therapeutics (CA, USA) is a pharmaceutical research company that develops an immuno-tumor vaccine to treat cancer.

11,703,869 BioPorto Diagnostics (Denmark) offers a wide range of diagnostic tests and antibodies to healthcare professionals in clinical and research settings.

11,800,000 DiaMedica (MN, USA) is a biopharmaceutical company that focuses on developing treatments for stroke.

11,897,999 ANGLE (United Kingdom) is a liquid biopsy company that provides cancer diagnostic products for the capture and harvest of circulating tumor cells.

12,500,000 Kala Pharmaceuticals (MA, USA) develops novel treatments for diseases that affect mucosal tissues.

12,600,000 Assembly Biosciences, Inc. (IN, USA) is a public biotechnology company and provider of oral biologic therapeutics.

13,260,000 Elutia (MD, USA) is a developer of customized tissue products intended to restore health and mobility to the greatest number of patients.

15,000,000 CASI (MD, USA) is a biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products.

20,000,005 NeuroBo (MA, USA) is a clinical-stage biotechnology company that develops and commercializes multimodal disease-modifying therapies.

34,999,709 TissueGene (MD, USA) is a biopharmaceutical company focused on developing regenerative therapies for the treatment of various orthopaedic disorders.

40,000,000 Vaxart (CA, USA) is a biotechnology company that develops vaccine technology for the treatment of infectious diseases.

40,000,000 Vigil Neuroscience (MA, USA) is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.

50,000,000 Mereo (United Kingdom) is based in London and was founded to fund and develop novel, innovative specialist focused products from large pharmaceutical or biotechnology companies.

56,400,000 Rezolute (CO, USA) is a clinical-stage biopharma specializing in the development of drug therapies for patients with metabolic and orphan diseases.

59,667,778 Immutep (Australia) is a biopharmaceutical company developing immunotherapeutics in oncology.

75,000,000 Ascentage (China)is a clinical-stage biopharmaceutical company that develops drugs for the treatment of cancer.

75,000,000 Taysha Gene Therapies (TX, USA) develops treatments to eradicate severe and life-threatening monogenic diseases of the central nervous system.

100,000,000 Replimune Group (MA, USA) develop the next generation of ‘oncolytic immunotherapies’ for the treatment of cancer.

100,000,000 Entrada Therapeutics (MA, USA) is a developer of novel therapeutics intended to treat devastating diseases.

100,000,000 Savara Pharmaceuticals (TX, USA) develops an inhaled antibiotic for MRSA infection in cystic fibrosis.

107,500,000 UroGen Pharma (NY, USA) is a clinical-stage biopharmaceutical company focused on developing novel therapies.

114,271,702 Opthea Limited (Australia) is a public Australian biotechnology company developing novel biologic therapies for the treatment of eye diseases.

125,000,000 Annexon Biosciences (CA, USA) is a biotech company, discovering and developing novel therapeutics for neurodegenerative and autoimmune disorders.

130,700,000 Tectonic Therapeutic (MA, USA) is a biotechnology company which focuses on scientific research in biochemistry and molecular pharmacology.

140,000,000 Prokidney (OR, USA) provide specialized treatment for chronic kidney disease.

178,000,000 Disc Medicine (MA, USA) is a biopharmaceutical company that develops therapies for hematologic diseases and rare blood disorders.

200,000,000 Summit Therapeutics (United Kingdom) is a clinical-stage drug discovery and development company.

200,000,000 Recursion Pharmaceuticals (UT, USA) is a biotech company that develops a drug discovery platform and pipeline with machine learning.

350,000,000 Ultragenyx Pharmaceutical (CA, USA) focuses on the development of various products for the treatment of rare and ultra-rare diseases.

461,000,000 Avidity Biosciences (CA, USA) is a biotechnology company that develops oligonucleotide-based therapies for its patients.

547,400,000 Structure Therapeutics (CA, USA) specializes in the discovery and development of drugs against a type of targets called GPCR.

1,007,265,115 Zealand Pharma (Denmark) is a biotechnology company that offers scientific expertise in turning peptides into medicines.

 

post-ipo

 

Unknown Medios (Germany) is an innovative specialty pharmaceutical company that manufactures and supplies patient-specific medicinal products.

1,722,878,447 Shanghai Lai Shi Blood Products Co., Ltd. (China) is a leading manufacturer of blood products in China that integrates source plasma collection, blood products research and development, production and sales.

 

post-ipo debt

 

216,957 PreveCeutical Medical (Canada) is a health sciences company that develops innovative options for preventive and curative therapies.

1,500,000,000 Royalty Pharma (NY, USA) is an industry leader in investing in marketed and late stage biopharmaceutical products.

2,000,000 Silo Pharma (NJ, USA) is a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research.

3,200,000 Microbix Biosystems (Canada) develops biological products and technologies primarily for the diagnostics market.

77,583,793 Santhera Pharmaceuticals (Switzerland) develops and markets pharmaceutical products for the treatment of mitochondrial and neuromuscular diseases.

327,225,130 Grifols (Spain) is a leader in essential plasma-derived medicines and transfusion medicine, we develop, produce and provide innovative healthcare services and solutions in more than 110 countries.

900,000,000 Alvotech (Iceland) is a biotechnology company that specializes in making biosimilars to create biologic medicines.

2,487,694,393 Novartis (Switzerland) is a healthcare company that provides solutions to address the evolving needs of patients worldwide.

 

debt-financing

 

111,323 Xemperia (Switzerland) provides diagnostic solutions that helps to detect breast cancer and early diagnosis of relapses.

556,497 HemostOD (Switzerland) manufactures platelets on-demand from engineered stem cells.

1,000,000 Purinomia Biotech (MA, USA) provides biologicals and small molecule development to target key ectonucleotidases for the treatment of diseases.

 

non-equity assistance

 

Unknown Reme-D (NY, USA) develops diagnostic tests for underserved markets.

Unknown Syngens (Norway) is a DNA design company accelerating the transition to a sustainable future. We make biology predictable by combining AI with omics data.

 

unknown funding round

 

Unknown Ruiju Medical (China) is a developer of regenerative medicine biomaterials, specializing in efficient and precise R&D and manufacturing solutions.

Unknown Scilife’s (Belgium) Smart Quality Platform helps Life Science companies turn their QMS into a competitive advantage.

Unknown Genomes.io (United Kingdom) also offers the gold standard in genomic data protection. Using state-of-the art encryption and blockchain technologies, no one except you can view or access your data without your consent.

Unknown Jiajin Biotech (China) is a pharmaceutical R&D service provider. It specializes in the development of antibody-small nucleic acid conjugates.

Unknown BioMap (CA, USA) is a disruptive life science AI company responsible for building xTrimo, the first and largest protein-centric large language model platform.

Unknown Alderley Lighthouse Labs Limited (United Kingdom) is a laboratory-based testing facility, specialising in human diagnostics.

1,100,000 Inanovate (SA, USA) develops a longitudinal assay screening technology for the detection and measurement of multiple proteins.

1,913,087 Lightox (United Kingdom) has developed a unique range of molecular tools for use in imaging, therapeutics and assay development. These unique probes are smaller than any other commercially available fluorescent product. They offer the option of using our technologies as freely-moving probes that readily incorporate into cells or with a range of flexible linkers togive specificity to your unique applications and research needs.

2,000,000 NephroDI (PA, USA) Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.

2,105,106 AJNA BioSciences (CO, USA) is a botanical drug development company focused on psilocybin and other naturally derived psychedelics.

2,262,162 Codetta Bio (NC, USA) is a company developing quantitative & digital spatial platform for nucleic acid & protein assays.

2,800,000 Spinogenix (CA, USA) is a developer of a new class of therapeutics for neurodegenerative and psychiatric diseases.

3,200,000 SciTech (MI) Development is a specialty pharmaceutical company focusing on cancer treatments.

3,898,385 Response Pharmaceuticals (VA, USA) is a clinical-stage biopharmaceutical company focused on developing treatments for weight management and metabolic health in high-need patient populations.

4,916,907 NexEos Bio (PA, USA) detects, diagnoses, treats, and life-long manages patients living with chronic, eosinophil-related inflammatory diseases.

5,000,000 Ingenia Therapeutics (MA, USA) is a biotechnology company developing a therapeutic antibody candidate for capillary diseases.

5,000,000 ETHRIS (Germany) is a technical innovator in the emerging field of mRNA therapeutics and LNP delivery.

5,000,000 Mid-Atlantic BioTherapeutics (PA, USA) they are focused on the clinical development and commercialization of a novel anti-infective therapeutic approach, which is immunotherapy for infectious diseases.

5,515,000 Argon AI (NY, USA) is a platform that allows biopharmacy and life sciences experts to conduct complicated, data-driven operations using natural language. Argon AI helps professionals acquire detailed answers to inquiries about clinical trials, existing medicines, the healthcare landscape, and the competitive market in minutes, not months.

6,040,000 Myrtelle (MA, USA) is a gene therapy company that offers clinical trials for the treatment of rare monogenetic disorders.

7,000,000 Rarity Bioscience (Sweden) provides multiplex assays for detecting nucleic acid sequences in biological samples like liquid biopsies.

14,066,280 CATUG (China) is focused on the development and application of new biomedical technologies.

15,499,990 Notch (Canada) develops immune cell therapy developing a next-generation pipeline that is compatible and focuses on initial cancer cells.

18,500,000 NeOnc Technologies (CA, USA) develops intranasal inhalation dosing therapies for the treatment of brain and lung cancers.

20,000,000 RareCyte (WA, USA) is a life science research and diagnostic development company focused on characterizing and isolating rare cells in the blood.

22,948,872 Astrin Biosciences (MN, USA) is a biotechnology research center for 3D holographic images and learning.

 

*All findings throughout this blog article were founded from Crunchbase (2024). Crunchbase is the leading destination for company insights from early-stage startups to the Fortune 1000.)

 


 

If you’re a biotech startup looking for talent, or you’d like to learn more about our recruitment services, submit your vacancy and a recruitment consultant that specialises in your biotech field will be in touch shortly.

Alternatively, are you seeking advice on your next move? I’m here to help. Register with us today to schedule a confidential discussion about your career prospects.